Pcl Inc. (241820)

Overview

PCL, Inc. is a distinguished biotech company specialized in delivering innovative solutions in the multiplex in vitro diagnostic (IVD) products and platform services sector. Since its inception in 2008, PCL, Inc. has been at the forefront of developing advanced diagnostic systems and kits that cater to a wide array of medical testing needs including blood screening, cancer screening, autoimmune testing, and infectious diseases among others. Headquartered in Seoul, South Korea, the company has made significant strides in automating and accelerating the diagnostic process with its cutting-edge technologies, particularly in the wake of the global COVID-19 pandemic. Through its commitment to excellence and innovation, PCL, Inc. aims to improve patient outcomes and enhance the efficiency of healthcare services worldwide.

Products and Services

• HiSU Solution
  

  An automated multi-immune diagnostic system designed to perform a wide range of high-speed tests including blood screening, multiple cancer screenings, and autoimmune testing. This innovative system streamlines the diagnostic process, ensuring rapid and accurate results.

• Antigen and Antibody Diagnostic Kits
  

  Comprehensive kits such as PCLOK II anti-HIV/HCV/syphilis and PCLOK II HBsAg/HIV p24 are offered to detect various infections through precise antigen and antibody assessments, facilitating early and accurate diagnosis.

• Platform Services
  

  PCL, Inc. provides specialized platform services including SG ID, which is pivotal in identifying novel target substances. These services support the development of new diagnostic methods and the enhancement of existing processes.

• COVID-19 Solutions
  
  • PCLMD nCoV one step RT-PCR and PCL COVID19 speed RTPCR are advanced molecular diagnostic kits designed for the rapid and precise detection of COVID-19.
  • PCLMD ABC multi RTPCR provides a comprehensive molecular diagnostic solution for detecting the virus alongside other respiratory pathogens.
  • PCL COVID19 Ag rapid FIA and PCL COVID19 Ag gold are antigen diagnostic kits that offer quick and reliable screening for COVID-19.
  • PCL COVID19 IgG/IgM rapid gold and PCL COVID19 total Ab EIA are antibody diagnostic kits that help in assessing the immune response to COVID-19, indicating past or present infections.